Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Environmental
- Manufacturing, Other
- Agriculture
- Health and Safety
- Energy
- University / Academia / Research
- Food and Beverage
- Waste and Recycling
- Air and Climate
- Aerospace & Air Transport
- Water and Wastewater
- Soil and Groundwater
- Mining
- Glassware
- Metal
- Construction & Construction Materials
- Banking & Finance / Insurance / Legal
- Retail
- Plastics & Resins
- Pulp & Paper
- Oil, Gas & Refineries
- Government
Drug Development Suppliers Serving Lesotho
313 companies found
Premium
based inJena, GERMANY
Analytik Jena is a leading provider of high-end analytical measuring technology, instruments, and products in the fields of biotechnology and molecular diagnostics and high quality liquid handling and automation technologies. ...
based inPasadena, VIRGINIA (USA)
Parsons, an engineering, construction, technical, and management services firm with revenues of $3 billion in 2013, is 100% owned by the Employee Stock Ownership Trust. Parsons is a leader in many diversified markets with a focus on transportation, ...
An integrated approach for project success Parsons supports its life sciences customers with commissioning, qualifications, and validation needs by routinely performing validation planning for biotechnology, active pharmaceutical ingredients, dosage ...
based inTokyo, JAPAN
Nissan Chemical Corporation contributes to society with superior technology, products, and services, while striving for harmony with the environment. Our business activities are based on our corporate philosophy, 'Contribute to the protection of the ...
This is an antihypercholesterolemic agent characteristic of having a strong LDL cholesterol reduction effect and causing less drug-interactions. It is recognized as one of the “Strong statins” in clinical practice. In ...
based inSeattle, WASHINGTON (USA)
Nexelis is your partner for assay and biomarker development, advanced bioanalytical and laboratory testing, and translational immunology. As the leading specialty laboratory, we have unrivaled expertise in immunology, specifically in the areas of ...
Testing Services to Support Your Preclinical and Phase I-IV Drug Programs. Nexelis, a Q² Solutions Company, provides biomarker assay services in inflammation and immunology, oncology, organ injury (renal), nutritional health, ...
based inElma, NEW YORK (USA)
Quickset Defense Technologies, LLC, aka Quickset formerly known as Moog Sensor and Surveillance Systems, designs and produces high-quality positioners and scalable physical security and process monitoring solutions for extreme environments. Our ...
The CURLIN PainSmart IOD (Information on Demand) is built on the proven CURLIN 6000 ambulatory infusion platform to bring a unique electronic infusion device designed to safely deliver PCA, PCEA, and Subcutaneous infusions. When paired with ...
based inOxford, UNITED KINGDOM
Founded in 2012, we are the leading pharmatech company and the first to automate drug discovery. As a full stack AI drug discovery company, we generate our own data before combining the analytical power of AI with the creativity and expertise of our ...
based inOttawa, ONTARIO (CANADA)
Virica was founded in 2018 based on a decade of research in the laboratory of Dr. Jean-Simon Diallo at the Ottawa Hospital Research Institute. Dr. Diallo was investigating novel oncolytic viral therapies (OVTs) and recognized the need for VSEs to ...
Gene therapies and vaccines save and protect human life. The COVID-19 pandemic highlights the criticality of vaccine development today and into the future. The pandemic also highlights the challenges drug ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
ZW49 is a HER2-targeted antibody drug conjugate (ADC) developed using Zymeworks’ proprietary Azymetric™ and ZymeLink™ platforms. ZW49 is currently being evaluated in a Phase 1 clinical trial as a ...
based inKrakow, POLAND
We are one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. We have ...
based inLancaster, CALIFORNIA (USA)
Simulations Plus provides cutting-edge software solutions and consulting services designed to enhance drug discovery, clinical development, and regulatory submission processes. With over 25 years of experience, the company has established itself as ...
DILIsym is a sophisticated quantitative systems toxicology (QST) software designed to predict and elucidate drug-induced liver injury (DILI). This tool utilizes a middle-out, multi-scale modeling approach to simulate the complex ...
based inLake Forest, ILLINOIS (USA)
Since our founding over 25 years ago, Stericycle has grown from a small start-up in medical waste management into a leader across a range of increasingly complex and highly regulated arenas, including compliance and sustainability waste services, ...
based inLausanne, SWITZERLAND
Since 2016, SUN bioscience has been revolutionizing Precision Health. Our mission is to empower personalized medicine by harnessing the potential of patient stem cells to identify the most effective drugs. At the heart of our groundbreaking efforts ...
based inDerio, SPAIN
Innoprot is a company specializing in the development and provision of high-quality cell lines and assays for use in research and drug discovery. They offer a wide array of G protein-coupled receptor (GPCR) cell lines, which are essential for ...
based inBagsværd, DENMARK
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. ...
Our proprietary GalXC technology leverages a naturally occurring biologic process, ribonucleic acid interference, RNAi, to create therapies that silence disease-causing genes. This platform enables Dicerna to create molecules that can ...
based inYork, UNITED KINGDOM
Kirkstall Ltd. is a biotechnology company, operating within the global organ-on-a-chip market. Established in 2006, our aim is to satisfy the overwhelming need for more human relevant science, brought about by the failures of traditional in vitro ...
based inMadison, WISCONSIN (USA)
BellBrook Labs is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. As a small, R&D-driven company, we identify areas where there is a strong need but a ...
based inBoston, MASSACHUSETTS (USA)
At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma, laboratories, and clinicians — aiming to provide patients with access to accurate diagnoses and effective ...
AISightTM is a web-based digital pathology slide viewing platform that enables the management and analysis of whole slide ...
based inCambridge, UNITED KINGDOM
Founded by Dr Mark Kotter and Florian Schuster, bit.bio is an award-winning human synthetic biology enterprise. bit.bio™s mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to ...
ioGlutamatergic Neurons have been reprogrammed from human induced pluripotent stem cells (iPSC) using our precise reprogramming technology: opti-ox™¹ (optimized inducible overexpression). Human stem cells, within days, convert into ...
based inTarrytown, NEW YORK (USA)
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently ...
based inSomerville, MASSACHUSETTS (USA)
Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted ...
Our lead product candidate, CP101, is an orally administered, Complete Consortia product candidate initially targeting the prevention of recurrent CDI. The Centers for Disease Control and Prevention considers CDI to be one of the top three most ...
